ICU and ventilator mortality among critically ill adults with COVID-19

Sara Auld; Mark Caridi-Scheible; James M. Blum; Chad J. Robichaux; Colleen S. Kraft; Jesse T. Jacob; Craig S. Jabaley; David Carpenter; Roberta Kaplow; Alfonso C. Hernandez; Max W. Adelman; Gregory S. Martin; Craig M. Coopersmith; David J. Murphy; Emory COVID-19 Quality and Clinical Research Collaborative

doi:10.1101/2020.04.23.20076737

Abstract

We report preliminary data from a cohort of adults admitted to COVID-designated intensive care units from March 6 through April 17, 2020 across an academic healthcare system. Among 217 critically ill patients, mortality for those who required mechanical ventilation was 29.7% (49/165), with 8.5% (14/165) of patients still on the ventilator at the time of this report. Overall mortality to date in this critically ill cohort is 25.8% (56/217), and 40.1% (87/217) patients have survived to hospital discharge. Despite multiple reports of mortality rates exceeding 50% among critically ill adults with COVID-19, particularly among those requiring mechanical ventilation, our early experience indicates that many patients survive their critical illness.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the following grants: NIH/NIAID K23 AI134182 (SCA), NIH/CTSA UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Investigators may contact the authors regarding the availability of data.

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.